221 related articles for article (PubMed ID: 22675422)
1. Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.
Chartrain M; Riond J; Stennevin A; Vandenberghe I; Gomes B; Lamant L; Meyer N; Gairin JE; Guilbaud N; Annereau JP
PLoS One; 2012; 7(5):e36762. PubMed ID: 22675422
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
Xiao J; Egger ME; McMasters KM; Hao H
BMC Cancer; 2018 Jun; 18(1):675. PubMed ID: 29929490
[TBL] [Abstract][Full Text] [Related]
3. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
4. Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance.
Luo Y; Ellis LZ; Dallaglio K; Takeda M; Robinson WA; Robinson SE; Liu W; Lewis KD; McCarter MD; Gonzalez R; Norris DA; Roop DR; Spritz RA; Ahn NG; Fujita M
J Invest Dermatol; 2012 Oct; 132(10):2440-2450. PubMed ID: 22622430
[TBL] [Abstract][Full Text] [Related]
5. Identification of cells initiating human melanomas.
Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
[TBL] [Abstract][Full Text] [Related]
6. The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.
Wouters J; Stas M; Gremeaux L; Govaere O; Van den Broeck A; Maes H; Agostinis P; Roskams T; van den Oord JJ; Vankelecom H
PLoS One; 2013; 8(10):e76550. PubMed ID: 24098529
[TBL] [Abstract][Full Text] [Related]
7. In-vitro study of the influence of octocrylene on a selected metastatic melanoma cell line.
Prunk Zdravković T; Zdravković B; Zdravković M; Dariš B; Lunder M; Ferk P
G Ital Dermatol Venereol; 2019 Apr; 154(2):197-204. PubMed ID: 28704989
[TBL] [Abstract][Full Text] [Related]
8. ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer.
Guo Q; Grimmig T; Gonzalez G; Giobbie-Hurder A; Berg G; Carr N; Wilson BJ; Banerjee P; Ma J; Gold JS; Nandi B; Huang Q; Waaga-Gasser AM; Lian CG; Murphy GF; Frank MH; Gasser M; Frank NY
J Biol Chem; 2018 Jul; 293(28):11166-11178. PubMed ID: 29789423
[TBL] [Abstract][Full Text] [Related]
9. Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities.
Sana G; Madigan JP; Gartner JJ; Fourrez M; Lin J; Qutob N; Narayan J; Shukla S; Ambudkar SV; Xia D; Rosenberg SA; Gottesman MM; Samuels Y; Gillet JP
J Invest Dermatol; 2019 Sep; 139(9):1985-1992.e10. PubMed ID: 30905807
[TBL] [Abstract][Full Text] [Related]
10. The influence of nano-TiO2 on metabolic activity, cytotoxicity and ABCB5 mRNA expression in WM-266-4 human metastatic melanoma cell line.
Zdravkovic B; Zdravkovic TP; Zdravkovic M; Strukelj B; Ferk P
J BUON; 2019; 24(1):338-346. PubMed ID: 30941990
[TBL] [Abstract][Full Text] [Related]
11. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
Lai CY; Schwartz BE; Hsu MY
Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
[TBL] [Abstract][Full Text] [Related]
12. The effect of micro-sized titanium dioxide on WM-266-4 metastatic melanoma cell line.
Prunk Zdravković T; Zdravković B; Lunder M; Ferk P
Bosn J Basic Med Sci; 2019 Feb; 19(1):60-66. PubMed ID: 30383985
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells.
Wu CP; Sim HM; Huang YH; Liu YC; Hsiao SH; Cheng HW; Li YQ; Ambudkar SV; Hsu SC
Biochem Pharmacol; 2013 Feb; 85(3):325-34. PubMed ID: 23153455
[TBL] [Abstract][Full Text] [Related]
14. Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line.
Lutz NW; Banerjee P; Wilson BJ; Ma J; Cozzone PJ; Frank MH
PLoS One; 2016; 11(8):e0161803. PubMed ID: 27560924
[TBL] [Abstract][Full Text] [Related]
15. Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.
Czyz M; Koprowska K; Sztiller-Sikorska M
Cancer Biol Ther; 2013 Feb; 14(2):135-45. PubMed ID: 23192276
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance is conferred on the model yeast Saccharomyces cerevisiae by expression of full-length melanoma-associated human ATP-binding cassette transporter ABCB5.
Keniya MV; Holmes AR; Niimi M; Lamping E; Gillet JP; Gottesman MM; Cannon RD
Mol Pharm; 2014 Oct; 11(10):3452-62. PubMed ID: 25115303
[TBL] [Abstract][Full Text] [Related]
17. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.
Frank NY; Schatton T; Kim S; Zhan Q; Wilson BJ; Ma J; Saab KR; Osherov V; Widlund HR; Gasser M; Waaga-Gasser AM; Kupper TS; Murphy GF; Frank MH
Cancer Res; 2011 Feb; 71(4):1474-85. PubMed ID: 21212411
[TBL] [Abstract][Full Text] [Related]
18. Genetically determined ABCB5 functionality correlates with pigmentation phenotype and melanoma risk.
Lin JY; Zhang M; Schatton T; Wilson BJ; Alloo A; Ma J; Qureshi AA; Frank NY; Han J; Frank MH
Biochem Biophys Res Commun; 2013 Jul; 436(3):536-42. PubMed ID: 23770371
[TBL] [Abstract][Full Text] [Related]
19. Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism.
Lee CAA; Banerjee P; Wilson BJ; Wu S; Guo Q; Berg G; Karpova S; Mishra A; Lian JW; Tran J; Emmerich M; Murphy GF; Frank MH; Frank NY
J Biol Chem; 2020 May; 295(22):7774-7788. PubMed ID: 32317280
[TBL] [Abstract][Full Text] [Related]
20. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.
Frank NY; Margaryan A; Huang Y; Schatton T; Waaga-Gasser AM; Gasser M; Sayegh MH; Sadee W; Frank MH
Cancer Res; 2005 May; 65(10):4320-33. PubMed ID: 15899824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
